SCHEMBL2829286

SCHEMBL2829286

CC(=O)c1ccc(OCC(=O)N2CCC(N3CCCC3)CC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 9/20 0.69
CYP2D6 P10635 1/20 0.63
CYP2C19 P33261 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
KDM4E B2RXH2 5/20 0.56
TDP1 Q9NUW8 3/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.53
POLB P06746 1/20 0.53
MBTD1 Q05BQ5 1/20 0.52
TP53BP1 Q12888 1/20 0.52
L3MBTL4 Q8NA19 1/20 0.52
L3MBTL3 Q96JM7 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ORAI1 Q96D31 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384355 0.90 KDM4E (0.70) ACHEKDM4ETDP1ALDH1A1SMN1; SMN2
SCHEMBL4383690 0.89 KDM4E (0.68) ACHECYP2D6CYP2C19NPSR1KDM4E
Hydrochloric Acid SCHEMBL4377279 0.89 KDM4E (0.68) ACHEKDM4ETDP1ALDH1A1SMN1; SMN2
SCHEMBL2829771 0.87 ACHE (0.73) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL335348 0.87 RAB9A (0.66) TDP1ALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL2836569 0.85 ACHE (0.72) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL182672 0.82 ACHE (0.68) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL2828800 0.81 ACHE (0.67) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL2831262 0.79 NPC1 (0.76) ACHECYP2D6CYP2C19NPSR1KDM4E
SCHEMBL15134834 0.79 POLB (0.68) ACHETDP1ALDH1A1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed